<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02640105</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2013/14</org_study_id>
    <nct_id>NCT02640105</nct_id>
  </id_info>
  <brief_title>Cluster Headache, Addictions and Vascular Function</brief_title>
  <acronym>CHAD</acronym>
  <official_title>Cluster Headache (CH), Addictions and Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cluster headache (CH) is one of the most painful primitive headaches. Developments in
      neuroimaging have demonstrated activation of the ipsilateral hypothalamic and orexinergic
      system, which is similar in patients with addictions. CH has strong links to the vascular
      system but there is no study measuring endothelial function in CH sufferers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have shown an association between Cluster headache (CH) and smoking. However,
      no data exists on the link between CH and other addictions, and impact of these addictions on
      clinical characteristics of the disease. In addition, despite the strong biological link
      between CH and the vascular system, systematic investigations about vascular functions in CH
      patients are lacking.

      This will be a prospective cohort study of 150 patients with CH, conducted in the Headache
      Center in Bordeaux, France.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Duration of active periods of cluster headache</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of active periods</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of cluster headache</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of attacks</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of active periods of cluster headache</measure>
    <time_frame>one year after inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of active periods</measure>
    <time_frame>one year after inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of cluster headache</measure>
    <time_frame>one year after inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of attacks</measure>
    <time_frame>one year after inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Existence of an addiction</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Existence of an addiction</measure>
    <time_frame>One year after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of Addiction</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of Addiction</measure>
    <time_frame>One year after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reactive Hyperemic Index (RHI)</measure>
    <time_frame>Day 0 (Inclusion visit)</time_frame>
    <description>Endothelial function measurement</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cluster Headache</condition>
  <arm_group>
    <arm_group_label>Patient with Cluster headache</arm_group_label>
    <description>Prospective follow-up of patient with Cluster headache</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurological clinical examination</intervention_name>
    <description>Diagnostic and description of cluster headache</description>
    <arm_group_label>Patient with Cluster headache</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychological clinical examination</intervention_name>
    <description>Scale and questionnaires</description>
    <arm_group_label>Patient with Cluster headache</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Psychopathological and cognitive questionnaires</description>
    <arm_group_label>Patient with Cluster headache</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>Blood sample for DNA collection</description>
    <arm_group_label>Patient with Cluster headache</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endothelial function measurement</intervention_name>
    <description>Endothelial function will be measured with a noninvasive Peripheral Arterial Tone (PAT) signal technology using the EndoPAT device</description>
    <arm_group_label>Patient with Cluster headache</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with cluster headache
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presenting a chronic or episodic cluster headache diagnosed according to the
             International Classification of Headache Disorders (ICH-D III) criteria, in active or
             inactive phase.

        Exclusion Criteria:

          -  Other primary headaches

          -  Subjects without social insurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Virginie DOUSSET</last_name>
    <phone>0556798711</phone>
    <email>virginie.dousset@chu-bordeaux.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie DOUSSET</last_name>
      <phone>0556798711</phone>
      <email>virginie.dousset@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>December 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2015</study_first_posted>
  <last_update_submitted>December 21, 2015</last_update_submitted>
  <last_update_submitted_qc>December 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Cluster Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

